These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 36051387

  • 1. Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus.
    Song J, Li N, Hu R, Yu Y, Xu K, Ling H, Lu Q, Yang T, Wang T, Yin X.
    Front Endocrinol (Lausanne); 2022; 13():949990. PubMed ID: 36051387
    [Abstract] [Full Text] [Related]

  • 2. PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus.
    Wang T, Song JF, Zhou XY, Li CL, Yin XX, Lu Q.
    BMC Med Genomics; 2021 Nov 12; 14(1):267. PubMed ID: 34772419
    [Abstract] [Full Text] [Related]

  • 3. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus.
    Song JF, Wang T, Zhu J, Zhou XY, Lu Q, Guo H, Zhang F, Wang Y, Li W, Wang DD, Cui YW, Lv DM, Yin XX.
    Clin Exp Pharmacol Physiol; 2015 Jan 12; 42(1):27-32. PubMed ID: 25311380
    [Abstract] [Full Text] [Related]

  • 4. Variants in PPARD-GLP1R are related to diabetic kidney disease in Chinese Han patients with type 2 diabetes mellitus.
    Song J, Zhuang Y, Pan X, Chen Y, Xie F.
    Heliyon; 2024 Aug 15; 10(15):e35289. PubMed ID: 39161836
    [Abstract] [Full Text] [Related]

  • 5. PPARD rs2016520 polymorphism is associated with metabolic traits in a large population of Chinese adults.
    Tang L, Lü Q, Cao H, Yang Q, Tong N.
    Gene; 2016 Jul 10; 585(2):191-5. PubMed ID: 26915488
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects.
    Hu C, Jia W, Fang Q, Zhang R, Wang C, Lu J, Xiang K.
    Diabet Med; 2006 Dec 10; 23(12):1307-12. PubMed ID: 17116180
    [Abstract] [Full Text] [Related]

  • 7. Associations of type 2 diabetes with common variants in PPARD and the modifying effect of vitamin D among middle-aged and elderly Chinese.
    Lu L, Wu Y, Qi Q, Liu C, Gan W, Zhu J, Li H, Lin X.
    PLoS One; 2012 Dec 10; 7(4):e34895. PubMed ID: 22509365
    [Abstract] [Full Text] [Related]

  • 8. A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients.
    Zhou X, Zhu J, Bao Z, Shang Z, Wang T, Song J, Sun J, Li W, Adelusi TI, Wang Y, Lv D, Lu Q, Yin X.
    Sci Rep; 2016 Nov 18; 6():37293. PubMed ID: 27857189
    [Abstract] [Full Text] [Related]

  • 9. GLP-1 receptor agonists stimulate ANGPTL8 production through the PI3K/Akt pathway in a GLP-1 receptor-dependent manner.
    Liu J, Yang K, Xiao W, Le Y, Lang S, Zhang J, Wei R, Yang J, Hong T.
    Peptides; 2018 Aug 18; 106():83-90. PubMed ID: 30003931
    [Abstract] [Full Text] [Related]

  • 10. PPARD rs2016520 polymorphism and circulating lipid levels connect with brain diseases in Han Chinese and suggest sex-dependent effects.
    Huang Y, Nie S, Zhou S, Li K, Sun J, Zhao J, Fei B, Wang Z, Ye H, Hong Q, Gao X, Duan S.
    Biomed Pharmacother; 2015 Mar 18; 70():7-11. PubMed ID: 25776471
    [Abstract] [Full Text] [Related]

  • 11. Positive association between PPARD rs2016520 polymorphism and coronary heart disease in a Han Chinese population.
    Ye HD, Li YR, Hong QX, Zhou AN, Zhao QL, Xu LM, Xu MQ, Xu XT, Tang LL, Dai DJ, Jiang DJ, Huang Y, Wang DW, Duan SW.
    Genet Mol Res; 2015 Jun 11; 14(2):6350-9. PubMed ID: 26125839
    [Abstract] [Full Text] [Related]

  • 12. Association of peroxisome proliferator-activated receptor delta and additional gene-smoking interaction on cardiovascular disease.
    Yang W, Mao S, Qu B, Zhang F, Xu Z.
    Clin Exp Hypertens; 2017 Jun 11; 39(2):114-118. PubMed ID: 28287878
    [Abstract] [Full Text] [Related]

  • 13. Metabolic Biomarkers in Adults with Type 2 Diabetes: The Role of PPAR-γ2 and PPAR-β/δ Polymorphisms.
    Reza-López SA, González-Gurrola S, Morales-Morales OO, Moreno-González JG, Rivas-Gómez AM, González-Rodríguez E, Moreno-Brito V, Licón-Trillo A, Leal-Berumen I.
    Biomolecules; 2023 Dec 14; 13(12):. PubMed ID: 38136661
    [Abstract] [Full Text] [Related]

  • 14. Variation in the peroxisome proliferator-activated receptor delta gene in relation to common metabolic traits in 7,495 middle-aged white people.
    Grarup N, Albrechtsen A, Ek J, Borch-Johnsen K, Jørgensen T, Schmitz O, Hansen T, Pedersen O.
    Diabetologia; 2007 Jun 14; 50(6):1201-8. PubMed ID: 17431579
    [Abstract] [Full Text] [Related]

  • 15. Protective role of +294 T/C (rs2016520) polymorphism of PPARD in Mexican patients with colorectal cancer.
    Rosales-Reynoso MA, Wence-Chavez LI, Arredondo-Valdez AR, Dumois-Petersen S, Barros-Núñez P, Gallegos-Arreola MP, Flores-Martínez SE, Sánchez-Corona J.
    Genet Mol Res; 2017 Jan 23; 16(1):. PubMed ID: 28128413
    [Abstract] [Full Text] [Related]

  • 16. Effect of TCF7L2 polymorphism on pancreatic hormones after exenatide in type 2 diabetes.
    Ferreira MC, da Silva MER, Fukui RT, do Carmo Arruda-Marques M, Azhar S, Dos Santos RF.
    Diabetol Metab Syndr; 2019 Jan 23; 11():10. PubMed ID: 30700996
    [Abstract] [Full Text] [Related]

  • 17. Polymorphism of the PPARD Gene and Dynamic Balance Performance in Han Chinese Children.
    Cao Y, Zhang Q, Chen J, Li Z, Zhou Z, Shen J, Wang D, Pan D, Wang Z, Ke D, Wang X, Lu D, Zhao Y, Cheng S, Shi Y.
    Hereditas; 2019 Jan 23; 156():15. PubMed ID: 31148953
    [Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptor-delta genotype influences metabolic phenotype and may influence lipid response to statin therapy in humans: a genetics of diabetes audit and research Tayside study.
    Burch LR, Donnelly LA, Doney AS, Brady J, Tommasi AM, Whitley AL, Goddard C, Morris AD, Hansen MK, Palmer CN.
    J Clin Endocrinol Metab; 2010 Apr 23; 95(4):1830-7. PubMed ID: 20200337
    [Abstract] [Full Text] [Related]

  • 19. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Andrulionyte L, Peltola P, Chiasson JL, Laakso M, STOP-NIDDM Study Group.
    Diabetes; 2006 Jul 23; 55(7):2148-52. PubMed ID: 16804087
    [Abstract] [Full Text] [Related]

  • 20. Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study.
    Guan Z, Du Y, Li R, Zhang S, Xu Y, Zhang X, Zhang F, Yin Y, Wu K, Li X, Li Y.
    Eur J Clin Pharmacol; 2022 May 23; 78(5):793-799. PubMed ID: 35079845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.